CLINICAL TRIALS PROFILE FOR DAPAGLIFLOZIN AND SAXAGLIPTIN HYDROCHLORIDE
All Clinical Trials for DAPAGLIFLOZIN AND SAXAGLIPTIN HYDROCHLORIDE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT01606007 ↗ | Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 Diabetes | Completed | AstraZeneca | Phase 3 | 2012-07-01 | The purpose of this study is to learn if a combination of BMS-477118 (Saxagliptin) and BMS -512148 (Dapagliflozin) added to Metformin can improve (decrease) Glycosylated Hemoglobin (Hemoglobin A1c) in patients with type 2 diabetes after 24 weeks of treatment. The safety of this treatment will also be studied. |
| NCT01619059 ↗ | Safety and Efficacy of Saxagliptin in Triple Therapy to Treat Subjects With Type 2 Diabetes | Completed | AstraZeneca | Phase 3 | 2012-06-01 | The purpose of this study is to learn if BMS-477118 (Saxagliptin) as part of a triple combination therapy can improve (decrease) hemoglobin A1c in patients with type 2 diabetes after 24 weeks of treatment compared to a 2 drug oral antidiabetic therapy. The safety of this treatment will also be studied. |
| NCT01646320 ↗ | Safety and Efficacy of Dapagliflozin in Triple Therapy to Treat Subjects With Type 2 Diabetes | Completed | AstraZeneca | Phase 3 | 2012-09-01 | The purpose of this study is to learn if BMS-512148 (Dapagliflozin) as part of a triple combination therapy can improve (decrease) hemoglobin A1c in patients with type 2 diabetes after 24 weeks of treatment compared to a 2 drug oral antidiabetic therapy. The safety of this treatment will also be studied. |
| NCT01662999 ↗ | Drug Interaction Study of Saxagliptin in Combination With Dapagliflozin in Healthy Participants | Completed | AstraZeneca | Phase 1 | 2012-08-01 | The purpose of this study is to evaluate whether the pharmacokinetics (body concentrations/metabolism of the drug) of Saxagliptin and Dapagliflozin are affected when they are administered together |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for DAPAGLIFLOZIN AND SAXAGLIPTIN HYDROCHLORIDE
Condition Name
Clinical Trial Locations for DAPAGLIFLOZIN AND SAXAGLIPTIN HYDROCHLORIDE
Trials by Country
Clinical Trial Progress for DAPAGLIFLOZIN AND SAXAGLIPTIN HYDROCHLORIDE
Clinical Trial Phase
Clinical Trial Sponsors for DAPAGLIFLOZIN AND SAXAGLIPTIN HYDROCHLORIDE
Sponsor Name
